ArticleJournal of Ayurveda and integrative medicine
Management of a patient of hypertriglyceridemia with Benign Prostate Hyperplasia through integrative medicine - A case report.
Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is a case report of a 60-year-old male, who was a patient of Benign Prostate Hyperplasia since 2019, diagnosed as having Hypertriglyceridemia (Serum Triglycerides-839 mg/dL) after routine screening in a Diagnostic Laboratory. Although these were two distinct disease entities, Charaka Samhita's concept of Srotas was taken into consideration for treatment, and drugs that reduced both Serum Triglyceride levels and Lower Urinary Tract Symptoms (LUTS) of BPH were chosen. Varanadi Kashaya and Shilajitvadi Bati were given as medicines and after one month of follow-up, Serum Triglycerides decreased to 283 mg/dL, and improvement in the form of reduction of hesitancy during urination was appreciated by the patient. Over the course of the next one and a half years, the patient's serum triglycerides level was monitored with the same two medicines, along with the addition of Vastyamayantaka Ghritam and improvement was seen at each follow-up appointment. Therefore, in people with obesity and disorders of urinary system, the medicines which act on the kidneys can be selected, since they serve as the common origin for Medovaha Srotas and Mutravaha Srotas.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.